Tuesday 27 October 2020
Home      All news      Contact us      RSS     
healtheuropa - 22 days ago

Farxiga granted Breakthrough Therapy Designation by FDA

Farxiga has been given Breakthrough Therapy Designation by the Food and Drug Administration (FDA) for patients with chronic kidney disease. Farxiga has recently shown encouraging early clinical results that demonstrate substantial clinical improvement in patients with and without Type 2 diabetes. This has led to the granting of its Breakthrough Therapy Status in the US [ ] The post Farxiga granted Breakthrough Therapy Designation by FDA appeared first on Health Europa.


Latest News
Hashtags:   

Farxiga

 | 

granted

 | 

Breakthrough

 | 

Therapy

 | 

Designation

 | 

Sources